Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Arthritis, psoriatic – diagnosis"'
Autor:
Coates, Laura C., Soriano, Enrique R., Corp, Nadia, Bertheussen, Heidi, Callis Duffin, Kristina, Campanholo, Cristiano, Chau, Jeffrey, Eder, Lihi, Fernández-Ávila, Daniel G., Fitzgerald, Oliver, Garg, Amit, Gladman, Dafna, Goel, Niti, Helliwell, Philip S., Husni, M. Elaine, Jadon, Deepak R., Katz, Arnon, Laheru, Dhruvkumar, Latella, John, Leung, Ying Ying, Lindsay, Christine, Lubrano, Ennio, Mazzuoccolo, Luis Daniel, Mease, Philip J., O’Sullivan, Denis, Ogdie, Alexis, Olsder, Wendy, Palominos, Penelope Esther, Schick, Lori, Steinkoenig, Ingrid, de Wit, Maarten, van der Windt, D. A., Kavanaugh, Arthur, Helliwell, Philip, Laheru, Dhrukumar
Publikováno v:
Nature reviews rheumatology, 18(8), 465-479. Nature Publishing Group
Nature Reviews Rheumatology, 18(8), 465-479. Nature Publishing Group
Nature Reviews. Rheumatology, 18(8), 465-479. Nature Publishing Group
the GRAPPA Treatment Recommendations domain subcommittees 2022, ' Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) : updated treatment recommendations for psoriatic arthritis 2021 ', Nature Reviews Rheumatology, vol. 18, no. 8, pp. 465-479 . https://doi.org/10.1038/s41584-022-00798-0
Nature Reviews Rheumatology, 18(8), 465-479. Nature Publishing Group
Nature Reviews. Rheumatology, 18(8), 465-479. Nature Publishing Group
the GRAPPA Treatment Recommendations domain subcommittees 2022, ' Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) : updated treatment recommendations for psoriatic arthritis 2021 ', Nature Reviews Rheumatology, vol. 18, no. 8, pp. 465-479 . https://doi.org/10.1038/s41584-022-00798-0
Since the second version of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic options for psoriatic arthritis (PsA) have advanced considerably. This work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00d8f35d7763dd1bbfb4c82985b94f35
https://doi.org/10.1038/s41584-022-00798-0
https://doi.org/10.1038/s41584-022-00798-0
Autor:
Lykke M Ørnbjerg, Elisabeth Svensson, Katja Løngaard, Rikke H Meincke, Jens Kristian Pedersen, Lene Dreyer, Niels Steen Krogh, Dorte V Jensen, Merete L Hetland
Publikováno v:
Ørnbjerg, L M, Svensson, E, Løngaard, K, Meincke, R H, Pedersen, J K, Dreyer, L, Krogh, N S, Jensen, D V & Hetland, M L 2022, ' Conversion of the MDHAQ to the HAQ score-a simple algorithm developed and validated in a cohort of 13,391 real-world patients ', Rheumatology, vol. 61, no. 10, keac040, pp. 3919-3929 . https://doi.org/10.1093/rheumatology/keac040
Objectives To develop and validate in real-world patients a conversion algorithm from the Multidimensionel Health Assessment Questionnaire physical function scale (MDHAQ) to the Stanford Health Assessment Questionnaire disability index physical funct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a56e87f7bc3b3f065f52ee6614ad6f
https://doi.org/10.1093/rheumatology/keac040
https://doi.org/10.1093/rheumatology/keac040
Autor:
Hafsah Nabi, Oliver Hendricks, Dorte Vendelbo Jensen, Anne Gitte Loft, Jens Kristian Pedersen, Søren Andreas Just, Kamilla Danebod, Heidi Lausten Munk, Salome Kristensen, Natalia Manilo, Ada Colic, Asta Linauskas, Pia Høger Thygesen, Louise Brot Christensen, Maren Høgberget Kalisz, Niels Lomborg, Stavros Chrysidis, Johnny Lillelund Raun, Marlene Andersen, Frank Mehnert, Niels Steen Krogh, Merete Lund Hetland, Bente Glintborg
Publikováno v:
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, e002560 . https://doi.org/10.1136/rmdopen-2022-002560
Nabi, H, Hetland, M L, Loft, A G, Hendricks, O, Jensen, D, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Grydehøj, J, Raun, J, Ahmed, R, Mehnert, F, Krogh, N S & Glintborg, B 2022, ' INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0065, pp. 45-46 . https://doi.org/10.1136/annrheumdis-2022-eular.2306
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560
Nabi, H, Hetland, M L, Loft, A G, Hendricks, O, Jensen, D, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Grydehøj, J, Raun, J, Ahmed, R, Mehnert, F, Krogh, N S & Glintborg, B 2022, ' INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0065, pp. 45-46 . https://doi.org/10.1136/annrheumdis-2022-eular.2306
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560
ObjectiveSuccessful uptake of biosimilars in rheumatology is limited by lack of real-world evidence regarding effectiveness of biosimilar-to-biosimilar switching. We investigated infliximab biosimilars CT-P13-to-GP1111 switching among patients with r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcafac3b27cbee58119c12faba1e028
https://vbn.aau.dk/da/publications/1224b0b0-ee61-4f51-a117-2bb3d48fd527
https://vbn.aau.dk/da/publications/1224b0b0-ee61-4f51-a117-2bb3d48fd527
Autor:
Iskandar, Ireny, Chen, Teng-Chou, Chen, Li-Chia, Daniels, Sarah, Lee, Meng-Sui, Yang, Yen-Yun, Wang, Ting-Chun, Hsie, Yu-Chun, Chan, Kin-Wei Arnold, Griffiths, C. E. M., Ashcroft, Darren
Publikováno v:
Iskandar, I, Chen, T-C, Chen, L-C, Daniels, S, Lee, M-S, Yang, Y-Y, Wang, T-C, Hsie, Y-C, Chan, K-W A, Griffiths, C E M & Ashcroft, D 2022, ' Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study ', Acta Dermato-Venereologica, vol. 102, adv00807 . https://doi.org/10.2340/actadv.v102.1962
There is a recognized need to better understand changes in the epidemiology of psoriasis and psoriatic arthritis (PsA) over time in Asia. Using the Taiwan National Health Insurance claim records this population-based study examined changes in the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824bdaa85a0b15ac25172bbd33f09021
https://pubmed.ncbi.nlm.nih.gov/36065746
https://pubmed.ncbi.nlm.nih.gov/36065746
Autor:
Freddy Lättekivi, Irina Guljavina, Getnet Midekessa, Janeli Viil, Paul R. Heath, Rikke Bæk, Malene Møller Jørgensen, Aneta Andronowska, Kulli Kingo, Alireza Fazeli
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 7; Pages: 4005
Lättekivi, F, Guljavina, I, Midekessa, G, Viil, J, Heath, P R, Bæk, R, Jørgensen, M M, Andronowska, A, Kingo, K & Fazeli, A 2022, ' Profiling Blood Serum Extracellular Vesicles in Plaque Psoriasis and Psoriatic Arthritis Patients Reveals Potential Disease Biomarkers ', International Journal of Molecular Sciences, vol. 23, no. 7, 4005 . https://doi.org/10.3390/ijms23074005
Lättekivi, F, Guljavina, I, Midekessa, G, Viil, J, Heath, P R, Bæk, R, Jørgensen, M M, Andronowska, A, Kingo, K & Fazeli, A 2022, ' Profiling Blood Serum Extracellular Vesicles in Plaque Psoriasis and Psoriatic Arthritis Patients Reveals Potential Disease Biomarkers ', International Journal of Molecular Sciences, vol. 23, no. 7, 4005 . https://doi.org/10.3390/ijms23074005
Psoriasis vulgaris (PsV) and psoriatic arthritis (PsA) are inflammatory diseases with unresolved pathophysiological aspects. Extracellular vesicles (EVs) play an important role in intercellular communication. We compared the miRNA contents and surfac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59bb7aebfdc8f533a2d9786f9ec2f56d
https://eprints.whiterose.ac.uk/185833/1/ijms-23-04005-v2.pdf
https://eprints.whiterose.ac.uk/185833/1/ijms-23-04005-v2.pdf
Autor:
Kristien Van der Elst, Veerle Stouten, Diederik De Cock, D. Bertrand, Kurt de Vlam, Rene Westhovens, Pavlos Mamouris, Patrick Verschueren, S. Pazmino, Bert Vaes
Publikováno v:
RMD Open
RMD Open, Vol 7, Iss 2 (2021)
RMD Open, Vol 7, Iss 2 (2021)
ObjectivesRheumatoid arthritis (RA), psoriatic arthritis (PsA) and spondyloarthritis (SpA) are chronic inflammatory rheumatic conditions with high levels of comorbidity requiring additional therapeutic attention. We aimed to compare the 3-year comorb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40476558e3066409d723fc0bc7ae089d
https://doi.org/10.1136/rmdopen-2021-001671
https://doi.org/10.1136/rmdopen-2021-001671
Autor:
Boehncke, Wolf-Henning
Publikováno v:
Der Hautarzt, Vol. 72, No 11 (2021) pp. 946-952
Background: Psoriatic arthritis is the most important "comorbidity" of psoriasis, which impacts the work of dermatologists in many ways.Objective: The relevance of joint involvement in psoriasis patients for the practicing dermatologist is considered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::cd57810be65c74b0325de93c82f12b93
https://archive-ouverte.unige.ch/unige:159774
https://archive-ouverte.unige.ch/unige:159774
Autor:
Pernilla Nikamo, Bjorn Gudbjornsson, Leena Laasonen, Leif Ejstrup, Lars Iversen, Ulla Lindqvist, Leonid Padyukov, Mona Ståhle
Publikováno v:
Nikamo, P, Gudbjornsson, B, Laasonen, L, Ejstrup, L, Iversen, L, Lindqvist, U, Padyukov, L & Ståhle, M 2020, ' HLA-B*27 is significantly enriched in Nordic patients with psoriatic arthritis mutilans ', Clinical and Experimental Rheumatology, vol. 39, no. 4 .
Aarhus University
Nikamo, P, Gudbjornsson, B, Laasonen, L, Ejstrup, L, Iversen, L, Lindqvist, U, Padyukov, L & Ståhle, M 2020, ' HLA-B*27 is significantly enriched in Nordic patients with psoriatic arthritis mutilans ', Clinical and Experimental Rheumatology, vol. 39, no. 4, pp. 775-780 . < https://pubmed.ncbi.nlm.nih.gov/32896263/ >
Aarhus University
Nikamo, P, Gudbjornsson, B, Laasonen, L, Ejstrup, L, Iversen, L, Lindqvist, U, Padyukov, L & Ståhle, M 2020, ' HLA-B*27 is significantly enriched in Nordic patients with psoriatic arthritis mutilans ', Clinical and Experimental Rheumatology, vol. 39, no. 4, pp. 775-780 . < https://pubmed.ncbi.nlm.nih.gov/32896263/ >
OBJECTIVES: The genetic contribution to psoriatic disease is substantial with a dominating influence of the HLA region. The profile of HLA class I genotypes likely contributes to shaping clinical phenotypes. Herein we aimed to explore such genotypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eacd819ecf5eeeb9f1cf5654cf34b1c4
https://pure.au.dk/portal/da/publications/hlab27-is-significantly-enriched-in-nordic-patients-with-psoriatic-arthritis-mutilans(8aa5964c-7278-4639-acf5-30cabd0c5397).html
https://pure.au.dk/portal/da/publications/hlab27-is-significantly-enriched-in-nordic-patients-with-psoriatic-arthritis-mutilans(8aa5964c-7278-4639-acf5-30cabd0c5397).html
Autor:
Alexis Ogdie, Philip J. Mease, William Tillett, Vibeke Strand, Laura C. Coates, Niti Goel, Lihi Eder, Ying Ying Leung, Christine A. Lindsay, Anna Antony, Dafna D. Gladman, Richard Holland, Ana Maria Orbai, Kristina Callis Duffin, Maarten de Wit, O. FitzGerald
Publikováno v:
Leung, Y Y, Tillett, W, Orbai, A-M, Ogdie, A, Eder, L, Coates, L C, Holland, R, Antony, A, Goel, N & Mease, P J 2020, ' The GRAPPA-OMERACT Working Group : 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates ', The Journal of Rheumatology and Supplements, vol. 96, pp. 46-49 . https://doi.org/10.3899/jrheum.200127, https://doi.org/10.3899/jrheum.200127
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) working group provided updates at the 2019 GRAPPA annual meeting on its work toward developing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d39cbeeec01f61fedad468555615c15
https://ora.ox.ac.uk/objects/uuid:b4ff6b11-ce62-400a-8188-246ca2d0748b
https://ora.ox.ac.uk/objects/uuid:b4ff6b11-ce62-400a-8188-246ca2d0748b
Autor:
F. Ganz, Ediz Dalkilic, S.A.L. Lima, R. Horváth, Wolf-Henning Boehncke, M. Okada, Ennio Lubrano, M. Hojnik
Publikováno v:
Journal of the European Academy of Dermatology and Venereology, Vol. 34, No 9 (2020) pp. 2035-2043
Background Psoriatic arthritis (PsA) is a chronic and debilitating disease that can be managed by different clinical specialists. Objectives The objective of theLOOPstudy was to evaluate the impact of clinical specialty setting on the time to diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::defd6b59ba77264778880491aacfba81
http://hdl.handle.net/11452/30591
http://hdl.handle.net/11452/30591